Consolidated Statement Of Profit Or Loss

ONO PHARMACEUTICAL CO., LTD. - Filing #7302958

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
240,339,000,000 JPY
258,713,000,000 JPY
Cost of sales
56,877,000,000 JPY
64,765,000,000 JPY
Gross profit
183,462,000,000 JPY
193,948,000,000 JPY
Selling, general and administrative expenses
58,424,000,000 JPY
47,604,000,000 JPY
Other income
572,000,000 JPY
894,000,000 JPY
Other expenses
928,000,000 JPY
842,000,000 JPY
Operating profit (loss)
55,881,000,000 JPY
97,036,000,000 JPY
Finance income
2,276,000,000 JPY
2,321,000,000 JPY
Finance costs
3,522,000,000 JPY
64,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
2,000,000 JPY
4,000,000 JPY
Profit (loss) before tax
54,637,000,000 JPY
99,296,000,000 JPY
Income tax expense
12,990,000,000 JPY
24,776,000,000 JPY
Profit (loss)
41,641,000,000 JPY
41,641,000,000 JPY
41,647,000,000 JPY
6,000,000 JPY
74,491,000,000 JPY
74,491,000,000 JPY
29,000,000 JPY
74,520,000,000 JPY
Profit (loss) attributable to
Owners of parent
41,641,000,000 JPY
74,491,000,000 JPY
Non-controlling interests
6,000,000 JPY
29,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
88.66
153.33
Diluted earnings (loss) per share
88.61
153.32

Talk to a Data Expert

Have a question? We'll get back to you promptly.